CapForce IBD Breakout Opportunities ETF
BOUT
5 hedge funds and large institutions have $4.09M invested in CapForce IBD Breakout Opportunities ETF in 2018 Q3 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
30.44% more ownership
Funds ownership: 0% → 30.44% (+30%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$2.2M |
| 2 |
AIP
Ahrens Investment Partners
Lafayette,
Louisiana
|
+$825K |
| 3 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$610K |
| 4 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$325K |
| 5 |
CPIG
Chicago Partners Investment Group
Chicago,
Illinois
|
+$172K |
Top Sellers
BOUT Hedge Fund Activity: Q3 2018 in Review
5 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in CapForce IBD Breakout Opportunities ETF (BOUT) for Q3 2018, worth a combined $4.09M.
Buyers outnumbered sellers: 5 funds opened new BOUT positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $2.2M.
- 5 institutional investors held CapForce IBD Breakout Opportunities ETF (BOUT) as of Q3 2018, up from 0 in Q2 2018.
- Funds reported $4.09M of CapForce IBD Breakout Opportunities ETF stock for Q3 2018.
- 5 funds opened new CapForce IBD Breakout Opportunities ETF positions in Q3 2018 and 0 closed out, a net change of +5 holders.
- The largest CapForce IBD Breakout Opportunities ETF buyer in Q3 2018 was Jane Street, an estimated $2.2M added.
Based on aggregated 13F filings for Q3 2018.